Corient Private Wealth’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.71M Sell
41,842
-52,132
-55% -$3.87M ﹤0.01% 1103
2025
Q4
$7.19M Buy
93,974
+52,535
+127% +$4.02M ﹤0.01% 893
2025
Q3
$3.03M Sell
41,439
-2,794
-6% -$205K ﹤0.01% 898
2025
Q2
$3.35M Sell
44,233
-3,952
-8% -$280K ﹤0.01% 837
2025
Q1
$3.66M Sell
48,185
-6,084
-11% -$453K 0.01% 778
2024
Q4
$3.59M Sell
54,269
-5,352
-9% -$375K 0.01% 802
2024
Q3
$4.16M Sell
59,621
-619
-1% -$37.2K 0.01% 809
2024
Q2
$3.19M Buy
+60,240
New +$3.66M 0.01% 848

Other funds holding SOLV

Corient Private Wealth's SOLV Position: Q1 2026 in Review

Corient Private Wealth reduced its Solventum (SOLV) stake by 55% in Q1 2026, selling an estimated $3.87M and leaving 41,842 shares worth $2.71M. The position accounts for ﹤0.01% of the portfolio, ranked #1103.

Corient Private Wealth first reported a position in SOLV in Q2 2024 and has held it in 8 quarters since. The position peaked at $7.19M in Q4 2025. 877 funds tracked by Wall St. Rank hold SOLV as of Q1 2026.

  • Corient Private Wealth held 41,842 shares of Solventum worth $2.71M as of Q1 2026.
  • Corient Private Wealth sold 52,132 Solventum shares in Q1 2026, an estimated $3.87M.
  • Solventum made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #1103 holding.
  • Corient Private Wealth first reported a position in Solventum in Q2 2024 and has held it in 8 quarters since.
  • Corient Private Wealth's Solventum position peaked at $7.19M in Q4 2025.
  • 877 funds tracked by Wall St. Rank held Solventum as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.